Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis. [electronic resource]
Producer: 20161213ISSN:- 2047-9980
- Adolescent
- Age Factors
- Antibodies, Monoclonal -- adverse effects
- Antilymphocyte Serum -- adverse effects
- Basiliximab
- Cause of Death
- Chi-Square Distribution
- Child
- Child, Preschool
- Databases, Factual
- Female
- Heart Transplantation -- adverse effects
- Humans
- Immunosuppressive Agents -- adverse effects
- Induction Chemotherapy
- Kaplan-Meier Estimate
- Male
- Multivariate Analysis
- Proportional Hazards Models
- Recombinant Fusion Proteins -- adverse effects
- Registries
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Time Factors
- Tissue and Organ Procurement
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.